Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic role of microRNA polymorphisms in patients with advanced esophageal squamous cell carcinoma receiving platinum-based chemotherapy.

Cancer chemotherapy and pharmacology - 1 Feb 2014

Wu Chaohui, Li Minjie, Hu Chao, Duan Hongbing

Abstract excerpt

PURPOSE: MicroRNA (miRNA) polymorphisms contribute to cancer susceptibility and prognosis. The aim of this study was to evaluate the effects of miRNA polymorphisms on clinical outcomes in patients with advanced esophageal squamous cell carcinoma (ESCC) treated with platinum-based chemotherapy. METHODS: Five polymorphisms (miR-146a rs2910164, miR-196a2 rs11614913, miR-100 rs1834306, miR-125a rs12976445 and...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Carcinoma, Squamous Cell
Share to Esophageal Neoplasms
Share to Esophageal Squamous Cell Carcinoma
Share to Kaplan-Meier Estimate
Share to MicroRNAs
Share to Organoplatinum Compounds
Share to Prognosis

Source

Identifiers

PMID: 24288122
DOI: 10.1007/s00280-013-2364-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic role of microRNA polymorphisms in patients with advanced esophageal squamous cell carcinoma receiving platinum-based chemotherapy.PMID 24288122Read ↗

Association between miR-146a rs2910164, miR-196a2 rs11614913, and miR-499 rs3746444 polymorphisms and the risk of esophageal carcinoma: A case-control study.Semantic proximity Read ↗

MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population.Semantic proximity Read ↗

Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk.Semantic proximity Read ↗

Hsa-miR-196a2 functional SNP is associated with severe toxicity after platinum-based chemotherapy of advanced nonsmall cell lung cancer patients in a Chinese population.Semantic proximity Read ↗

Prognostic role of common microRNA polymorphisms in cancers: evidence from a meta-analysis.Semantic proximity Read ↗

MicroRNAs related polymorphisms and genetic susceptibility to esophageal squamous cell carcinoma.Semantic proximity Read ↗

The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies.Semantic proximity Read ↗

The association between four genetic variants in microRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies.Semantic proximity Read ↗

Association between common genetic variants in pre-microRNAs and prognosis of advanced gastric cancer treated with chemotherapy.Semantic proximity Read ↗

Association of miRNA-related genetic polymorphisms and prognosis in patients with esophageal squamous cell carcinoma.Semantic proximity Read ↗

Evaluation of common genetic variants in pre-microRNA in susceptibility and prognosis of esophageal cancer.Semantic proximity Read ↗

Association of the miR-146a rs2910164 polymorphism with gastric cancer susceptibility and prognosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.